Two previous reports on the analysis of EZH2 Y646 mutations in B-cell NHL have compared initial and recurrent samples from the same patients.6–27 In both studies, however, only histological specimens were used, and comparisons were available for only 2 specimens from the same case. This evidence concerns the gene EZH2 and B-cell non-Hodgkin lymphoma.